Global AI In Pharma Market Report 2024

AI In Pharma Global Market Report 2024 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $4000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
AI In Pharma Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Ai In Pharma Market Definition And Segments

AI in pharma refers to the use of automated algorithms for jobs that normally need human intelligence. Large datasets including disease patterns can be successfully identified by AI solutions in pharma, and they can also assist in understanding which medication formulations would be most effective for treating certain ailments.

The artificial intelligence (AI) in the pharma market covered in the report is segmented by technology into context-aware processing, natural language processing, querying method, and deep learning; by drug type into small molecule, and large molecules, by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

The AI in pharma market covered in this report is segmented –

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

The AI in pharma market size has grown exponentially in recent years. It will grow from $1.58 billion in 2023 to $2.06 billion in 2024 at a compound annual growth rate (CAGR) of 30.4%. The growth in the historic period can be attributed to increased adoption of artificial intelligence (AI) for cost efficient drug discovery and rising implementation of AI in radiology.

The AI in pharma market size is expected to see exponential growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 28.5%. The growth in the forecast period can be attributed to adoption of cloud-based applications and services by pharma companies, increasing healthcare expenditure and growing government support rising to AI development. Major trends in the forecast period include introduction of generative AI in pharma, use of AI in molecular target identification, integration of AI in drug screening process, advancements in AI tools for the pharmaceutical industry, growing investments to develop new product solutions and strategic partnerships and collaborations among market players.

Government Backing Fuels Growth Of AI In Pharma Market With Financial Programs And Research Initiatives

The growing government support for AI development is expected to propel the growth of the AI in pharma market going forward. Governments recognize the potential of AI technologies in revolutionizing the pharma sector and they are increasingly implementing policies and initiatives to promote their adoption. Many countries have developed national AI strategies that include a focus on healthcare and pharmaceutical applications. These strategies aim to stimulate the development and utilization of AI technology to promote scientific development and solve real problems in the country. For example, in April 2022, the Australian government announced a financing program worth AUD44 million ($29.61 million) to support AI research among small and medium-sized enterprises (SMEs). This initiative is part of a broader strategy to increase the application of AI in Australia's national manufacturing priority sectors and digital growth priority areas, which include the pharmaceutical industry. The funding will be used to establish digital capability centers, which will serve as hubs for AI research and development. These centers will provide resources, training, and support to SMEs, helping them to develop and implement AI technologies. Therefore, the growing government support will drive the growth of the AI in pharma market during the forecast period.

Cloud-Based Drug Discovery Platforms Propel AI Adoption In Pharma For Enhanced Research And Collaboration

The rising adoption of cloud-based applications and services by pharmaceutical companies is expected to propel the growth of the AI in pharma market going forward. Cloud-based drug discovery platforms are a cutting-edge method of conducting research and development in the pharmaceutical industry. They leverage data analytics and cloud computing technologies to enhance drug discovery procedures, offering a wide range of tools and functionalities necessary for different facets of drug research and discovery. These platforms improve the efficiency, economy, and collaboration of the processes. Pharmaceutical companies are significant market participants and end-users of these platforms, which help these companies handle large amounts of clinical, chemical, and biological data by providing secure data storage options. In March 2023, Nvidia Corporation, a US-based technology company, launched BioNeMo Cloud, to streamline life sciences research, drug discovery, and protein engineering. The software provides researchers with access to pre-trained AI models, allowing for customization with proprietary data. Offered as a cloud service, BioNeMo Cloud enables accelerated drug discovery workflows, with US-based biotech company Amgen and several startups already utilizing the platform. Therefore, the increasing adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma market growth during the forecast period.

Major companies operating in the AI in pharma market report are Concerto HealthAI, Alphabet Inc., OWKIN, Nvidia Corporation, PathAI, Insilico Medicine, Exscientia, Microsoft Corporation, XtalPi, Intel, Standigm, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co. Ltd. (Sinopharm), Jiangsu Hengrui Medicine Co. Ltd., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharma, Alliance Pharm Pte Ltd., Shanghai Pharmaceuticals, DeepMind, GlaxoSmithKline, Sanofi, Bayer, Renalytix AI, Merck, AstraZeneca, Iktos, Benevolent AI, Novartis, Ardigen, Botkin, Webiomed, Care Mentor AI, Diagnocat, IBM Corporation, Atomwise Inc., Cloud Pharmaceuticals, Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Cyclica, IQVIA, Roche, Pfizer, PRA Health Science, Gesto, Intensicare, Epitrack, Deep Genomics Inc., Welltok Inc., Oncora Medical, Recursion Pharmaceuticals Inc., Nucleai, Pepticom, Rology, hearX Group, DilenyTech, iNNOHEALTH Technology Solutions

Introduction Of Advanced AI Tools By Pharma Companies Marks A Pivotal Trend In The Industry

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in the pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization, and process automation. For instance, in August 2022, Sanford Health, a US-based non-profit, integrated healthcare delivery system, and Sharp HealthCare, a US-based non-profit organization in healthcare partnered with Dandelion Health, a US-based healthcare artificial intelligence (AI) company, introduced a comprehensive data platform that gives health institutions access to high-quality, representative patient data for clinical AI development. The Dandelion Platform is made to give health AI developers secure, ethical access to patient datasets which include images, waveforms, and structured health records, so they may make tools and products that will help patients and clinicians.

Companies Embrace Generative AI In Pharma To Enhance Patient Interactions And Record Management

Companies in the market are increasingly focusing on using generative AI in pharma to improve medical consultations. Generative AI, a subfield of artificial intelligence that focuses on creating new data instances that resemble existing data, has been introduced into the pharmaceutical industry with the potential to revolutionize drug discovery and development and medical records management. For example, in October 2023, Ubie, a Japan-based medical AI startup, introduced a new Generative AI feature for doctors that streamlines medical record documentation and summarizes patient findings. This feature, known as the 'Medical Interview Summary Function,' uses a Large Language Model (LLM) to generate AI-based summaries from patient visits, specifically summarizing the 20-30 questions related to symptoms and lifestyle habits that patients answer on the 'Ubie Medical Navi' product. The LLM presents this summary on the doctor's PC screen, allowing doctors to quickly understand the patient's symptoms and concerns, thereby improving the quality of medical consultations.

Nurosene Health Inc. Bolsters AI-Based Neuroscience Product Offerings With Acquisition Of Netramark Incorporated

In October 2021, Nurosene Health Inc., a Canada-based company focused on delivering innovative AI-based technology solutions that support mental performance and wellness acquired Netramark Incorporated for an undisclosed amount. Through this acquisition, Nurosene Health Inc. aims to strengthen its capabilities in AI-based neuroscience product offerings. Netramark Incorporated is a Canada-based pharma tech company that utilizes AI, novel mathematical methods, and quantum computing to optimize new drug development, clinical trials, treatment, and diagnosis.

North America was the largest region in the AI in pharma market in 2023. The regions covered in the AI in pharma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in pharma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The AI in the pharma market includes revenues earned by entities by implementing quality control, addressing supply chain problems in the production line, and minimizing material waste. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI) in pharma market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in pharma market statistics, including artificial intelligence (AI) in pharma industry global market size, regional shares, competitors with artificial intelligence (AI) in pharma market share, detailed artificial intelligence (AI) in pharma market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in pharma industry. This artificial intelligence (AI) in pharma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI In Pharma Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.06 billion
Revenue Forecast In 2033 $5.62 billion
Growth Rate CAGR of 28.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Concerto HealthAI; Alphabet Inc.; OWKIN; Nvidia Corporation; PathAI; Insilico Medicine; Exscientia; Microsoft Corporation; XtalPi; Intel; Standigm; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; China National Pharmaceutical Group Co. Ltd. (Sinopharm); Jiangsu Hengrui Medicine Co. Ltd; Cipla Limited; Aurobindo Pharma Limited; Dr. Reddy’s Laboratories Ltd.; Sun Pharma; Alliance Pharm Pte Ltd.; Shanghai Pharmaceuticals; DeepMind; GlaxoSmithKline; Sanofi; Bayer; Renalytix AI; Merck; AstraZeneca; Iktos; Benevolent AI; Novartis; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; IBM Corporation; Atomwise Inc.; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Cyclica; IQVIA; Roche; Pfizer; PRA Health Science; Gesto; Intensicare; Epitrack; Deep Genomics Inc.; Welltok Inc.; Oncora Medical; Recursion Pharmaceuticals Inc.; Nucleai; Pepticom; Rology; hearX Group; DilenyTech; iNNOHEALTH Technology Solutions
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. AI In Pharma Market Characteristics

    3. AI In Pharma Market Trends And Strategies

    4. AI In Pharma Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global AI In Pharma Market Size and Growth

    5.1. Global AI In Pharma Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global AI In Pharma Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global AI In Pharma Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. AI In Pharma Market Segmentation

    6.1. Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Context-Aware Processing

    Natural Language Processing

    Querying Method

    Deep Learning

    6.2. Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Small Molecule

    Large Molecules

    6.3. Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Diagnosis

    Clinical Trial Research

    Drug Discovery

    Research and Development

    Epidemic Prediction

    7. AI In Pharma Market Regional And Country Analysis

    7.1. Global AI In Pharma Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global AI In Pharma Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific AI In Pharma Market

    8.1. Asia-Pacific AI In Pharma Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China AI In Pharma Market

    9.1. China AI In Pharma Market Overview

    9.2. China AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India AI In Pharma Market

    10.1. India AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan AI In Pharma Market

    11.1. Japan AI In Pharma Market Overview

    11.2. Japan AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia AI In Pharma Market

    12.1. Australia AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia AI In Pharma Market

    13.1. Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea AI In Pharma Market

    14.1. South Korea AI In Pharma Market Overview

    14.2. South Korea AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe AI In Pharma Market

    15.1. Western Europe AI In Pharma Market Overview

    15.2. Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK AI In Pharma Market

    16.1. UK AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany AI In Pharma Market

    17.1. Germany AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France AI In Pharma Market

    18.1. France AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy AI In Pharma Market

    19.1. Italy AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain AI In Pharma Market

    20.1. Spain AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe AI In Pharma Market

    21.1. Eastern Europe AI In Pharma Market Overview

    21.2. Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia AI In Pharma Market

    22.1. Russia AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America AI In Pharma Market

    23.1. North America AI In Pharma Market Overview

    23.2. North America AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA AI In Pharma Market

    24.1. USA AI In Pharma Market Overview

    24.2. USA AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada AI In Pharma Market

    25.1. Canada AI In Pharma Market Overview

    25.2. Canada AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America AI In Pharma Market

    26.1. South America AI In Pharma Market Overview

    26.2. South America AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil AI In Pharma Market

    27.1. Brazil AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East AI In Pharma Market

    28.1. Middle East AI In Pharma Market Overview

    28.2. Middle East AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa AI In Pharma Market

    29.1. Africa AI In Pharma Market Overview

    29.2. Africa AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. AI In Pharma Market Competitive Landscape And Company Profiles

    30.1. AI In Pharma Market Competitive Landscape

    30.2. AI In Pharma Market Company Profiles

    30.2.1. Concerto HealthAI

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Alphabet Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. OWKIN

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Nvidia Corporation

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. PathAI

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. AI In Pharma Market Other Major And Innovative Companies

    31.1. Insilico Medicine

    31.2. Exscientia

    31.3. Microsoft Corporation

    31.4. XtalPi

    31.5. Intel

    31.6. Standigm

    31.7. Takeda Pharmaceutical Company Ltd.

    31.8. Otsuka Pharmaceutical Co. Ltd.

    31.9. China National Pharmaceutical Group Co. Ltd. (Sinopharm)

    31.10. Jiangsu Hengrui Medicine Co. Ltd

    31.11. Cipla Limited

    31.12. Aurobindo Pharma Limited

    31.13. Dr. Reddy’s Laboratories Ltd.

    31.14. Sun Pharma

    31.15. Alliance Pharm Pte Ltd.

    32. Global AI In Pharma Market Competitive Benchmarking

    33. Global AI In Pharma Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The AI In Pharma Market

    35. AI In Pharma Market Future Outlook and Potential Analysis

    35.1 AI In Pharma Market In 2028 - Countries Offering Most New Opportunities

    35.2 AI In Pharma Market In 2028 - Segments Offering Most New Opportunities

    35.3 AI In Pharma Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global AI In Pharma Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global AI In Pharma Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Concerto HealthAI Financial Performance
  • Table 75: Alphabet Inc. Financial Performance
  • Table 76: OWKIN Financial Performance
  • Table 77: Nvidia Corporation Financial Performance
  • Table 78: PathAI Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global AI In Pharma Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global AI In Pharma Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Concerto HealthAI Financial Performance
  • Figure 75: Alphabet Inc. Financial Performance
  • Figure 76: OWKIN Financial Performance
  • Figure 77: Nvidia Corporation Financial Performance
  • Figure 78: PathAI Financial Performance
Global Cybersecurity Services Market Opportunities And Strategies – Forecast To 2030 – Includes Cybersecurity Services Market Demand
Read More
Opportunities And Strategies Analysis For The Supply Chain Management Software Market – Includes Supply Chain Management Software Market Overview
Read More
Global Internet Of Things (IoT) Market Opportunities And Strategies – Forecast To 2030 – Includes Internet Of Things (IoT) Market Size
Read More
Global Ambulatory Surgical Centers IT Services Market 2022 – Market Opportunities And Strategies
Read More
The Business Research Company offers the open source intelligence market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the projection mapping market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the soc as a service market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the employment screening services market research report 2022 with industry size, share, segments and market growth
Read More
Big Data and Analytics Global Market Report 2024 – By Analytics Tools (Dashboard & Data Visualization, Self-Service Tools, Data Mining & Warehousing, Reporting, Other Analytics Tools), By Deployment Mode (On-Premise, Cloud), By Application (Customer Analytics, Supply Chain Analytics, Marketing Analytics, Pricing Analytics, Spatial Analytics, Workforce Analytics, Risk & Credit Analytics, Transportation Analytics, Other Applications), By End Use Industry (BFSI, Retail, Manufacturing, IT and Telecom, Government, Healthcare, Utility, Other End Use Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmaceutical API Manufacturing Global Market Report 2024 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharma Microbiology Testing Kits Global Market Report 2024 – By Product (Consumables, Equipment), By Test (Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests), By End User (Hospitals & Diagnostic Centers, Custom Lab Service Providers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pharmacies and Healthcare Stores Global Market Report 2024 – By Type (Pharmacies And Drug Stores, Food (Health) Supplement Stores, Other Healthcare And Personal Care Stores), By Ownership (Retail Chain, Independent Stores), By drug type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2024-2033
View Report
IoT Global Market Report 2024 – By Platform (Device Management, Application Management, Network Management), By Application (Building And Home Automation, Smart Energy And Utilities, Smart Manufacturing, Connected Logistics, Smart Retail, Smart Mobility And Transportation, Other Applications), By End Use Industry (BFSI, Retail, Government, Healthcare, Manufacturing, Transportation, IT & Telecom, Other End-User Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence Global Market Report 2024 – By Offering (Hardware, Software, Services), By Technology (Machine learning, Natural language processing, Context-Aware Computing, Computer Vision, Other Technologies (Image processing, Speech recognition)), By End-user Industry (Healthcare, Automotive, Agriculture, Retail, Marketing, Telecommunication, Defense, Aerospace, Media & Entertainment, Other End-User Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence Services Global Market Report 2024 – By Technology (Machine Learning, Computer Vision, Natural Language Processing (NLP), Other Technology), By Services Type (Managed Services, Professional Services), By Software Tools (Web-based and Cloud Application Programming Interface, Processing and Modeler, Archiving and Data Storage), By Application Type (Fraud Detection, Data Analytics & Visualization, Customer Service and Management, Risk Management, Compliance & Security), By End-User (Banking, Financial, and Insurance (BFSI), IT & Telecom, Retail, Manufacturing, Public Sector, Energy & Utility, Healthcare, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Information Technology Global Market Report 2024 – By Type (IT Services, Computer Hardware, Telecom, Software Products), By Organization Size (Large Enterprise, Small and Medium Enterprise), By End User (Financial Services, Retail & Wholesale, Manufacturing, Healthcare, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the ai in pharma market?

The artificial intelligence (AI) in pharma market consists of sales of AI in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost, and time. The market consists of revenue generated by artificial intelligence (AI) companies, which are applying in the pharmaceutical industry. Only goods and services traded between entities or sold to end consumers are included. request a sample here

How will the ai in pharma market drivers and restraints affect ai in pharma market dynamics? What forces will shape the ai in pharma industry going forward?

The ai in pharma market growth is aided by growing adoption of artificial intelligence (AI) for clinical trials research. However, some ai in pharma market restraints include lack of skilled professionals request a sample here

What is the forecast market size of the ai in pharma market?

The ai in pharma market forecast is expected to reach $5.94 billion in 2025 at a compound annual growth rate of 47%. request a sample here

How is the ai in pharma market segmented?

The global AI in pharma market is segmented -
1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction request a sample here

Which region has largest share, and what is the market size and growth by geography according to the ai in pharma global market report?

For more detail on this, request a sample here.

Who are the key players of the global ai in pharma market?

Top competitors in the ai in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise Inc., Exscientia, Cyclica, NVIDIA Corporation, XtalPi Inc., BenevolentAI, Cloud Pharmaceuticals Inc, BERG LLC request a sample here.

What are the key trends in the global ai in pharma market?

Major trends influencing the ai in pharma market include introducing new AI tools that will be beneficial for the pharma companies request a sample here.

What are the major opportunities in the ai in pharma market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global ai in pharma market, request a sample here.

How does the ai in pharma market relate to the overall economy and other similar markets?

request a sample here.

request a sample here.

request a sample here.